DCGI Clears Two-Dose Vaccine for People Aged 4–60 Years, Marking a Major Milestone in Dengue Prevention Japan-based Takeda Biopharmaceuticals has received approval from the Drug Controller General of India (DCGI) … Continue reading Takeda’s QDENGA Becomes India’s First Approved Dengue Vaccine After DCGI Nod